{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:23:59Z","timestamp":1790421839492,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Perianal fistulas in Crohn's disease are frequent and disabling, with a major impact on patients' quality of life. Cell-based therapy using mesenchymal stem cells represents new hope for these patients, but long-term efficacy remains challenging. In a pilot study, including patients with refractory complex perianal fistulas, autologous adipose-derived stromal vascular fraction (ADSVF) combined with microfat achieved combined remission in 60% of cases, with a good safety profile at 1 year. The purpose of this study is to assess whether these results were maintained at longer term. The safety and efficacy data of the ten patients were evaluated retrospectively 3 years after injection on the basis of clinical and radiological data. MRI were analysed according to the MAGNIFI-CD score. No adverse event was attributed to the experimental stem-cell treatment. Combined remission was achieved in 7 patients (70%) and associated with a significant improvement in the MAGNIFI-CD MRI score. In conclusion, the safety and efficacy of ADSVF and microfat injection in Crohn's disease fistulas were maintained at 3\u00a0years, demonstrating that this innovative strategy is effective in producing a long-lasting healing effect. The ongoing multicentre randomized placebo-controlled trial (NCT04010526) will be helpful to define the place for this approach in the current therapeutic arsenal.<\/jats:p>","DOI":"10.1186\/s13287-022-02738-x","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T12:20:02Z","timestamp":1644409202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn\u2019s disease"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9024-8541","authenticated-orcid":false,"given":"Lucas","family":"Guillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Grimaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Houser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Prost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Philandrianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Abellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Veran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Visee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Beyer-Berjot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadne","family":"Desjeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Dignat-George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Grimaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Serrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Magalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"2738_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/DCR.0b013e31825228b0","volume":"55","author":"TW Eglinton","year":"2012","unstructured":"Eglinton TW, Barclay ML, Gearry RB, Frizelle FA. The spectrum of perianal Crohn\u2019s disease in a population-based cohort. Dis Colon Rectum. 2012;55:773\u20137.","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"2738_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/apt.12906","volume":"40","author":"NA Yassin","year":"2014","unstructured":"Yassin NA, Askari A, Warusavitarne J, et al. Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn\u2019s disease. Aliment Pharmacol Ther. 2014;40(7):741\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"2738_CR3","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1097\/MIB.0000000000000148","volume":"20","author":"I Molendijk","year":"2014","unstructured":"Molendijk I, Nuij VJAA, van der Meulen-de Jong AE, van der Woude CJ. Disappointing durable remission rates in complex Crohn\u2019s disease fistula. Inflamm Bowel Dis. 2014;20:2022\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"2738_CR4","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Pan\u00e9s","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Assche GV, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016;388:1281\u201390.","journal-title":"Lancet"},{"key":"2738_CR5","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","volume":"154","author":"J Pan\u00e9s","year":"2018","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Assche GV, et al. Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology. 2018;154:1334-1342.e4.","journal-title":"Gastroenterology"},{"key":"2738_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13287-017-0598-y","volume":"8","author":"P Bora","year":"2017","unstructured":"Bora P, Majumdar AS. Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell Res Ther. 2017;8:145.","journal-title":"Stem Cell Res Ther"},{"key":"2738_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bjps.2015.10.015","volume":"69","author":"A Nguyen","year":"2016","unstructured":"Nguyen A, Guo J, Banyard DA, et al. Stromal vascular fraction: a regenerative reality? Part 1: current concepts and review of the literature. J Plast Reconstr Aesthet Surg. 2016;69:170\u20139.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2738_CR8","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1053\/j.gastro.2019.01.032","volume":"156","author":"M Serrero","year":"2019","unstructured":"Serrero M, Grimaud F, Philandrianos C, et al. Long-term safety and efficacy of local microinjection combining autologous microfat and adipose-derived stromal vascular fraction for the treatment of refractory perianal fistula in Crohn\u2019s disease. Gastroenterology. 2019;156:2335-2337.e2.","journal-title":"Gastroenterology"},{"key":"2738_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13287-017-0736-6","volume":"9","author":"C Philandrianos","year":"2018","unstructured":"Philandrianos C, Serrero M, Grimaud F, et al. First clinical case report of local microinjection of autologous fat and adipose-derived stromal vascular fraction for perianal fistula in Crohn\u2019s disease. Stem Cell Res Ther. 2018;9:4.","journal-title":"Stem Cell Res Ther"},{"key":"2738_CR10","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1053\/j.gastro.2019.07.027","volume":"157","author":"P Hindryckx","year":"2019","unstructured":"Hindryckx P, Jairath V, Zou G, et al. Development and validation of a magnetic resonance index for assessing fistulas in patients with Crohn\u2019s disease. Gastroenterology. 2019;157:1233-1244.e5.","journal-title":"Gastroenterology"},{"key":"2738_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.retram.2016.10.006","volume":"65","author":"A Daumas","year":"2017","unstructured":"Daumas A, Magalon J, Jouve E, et al. Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients. Curr Res Transl Med. 2017;65:40\u20133.","journal-title":"Curr Res Transl Med"},{"key":"2738_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/biom11010082","volume":"11","author":"JZ-H Ko","year":"2021","unstructured":"Ko JZ-H, Johnson S, Dave M. Efficacy and safety of mesenchymal stem\/stromal cell therapy for inflammatory bowel diseases: an up-to-date systematic review. Biomolecules. 2021;11:82.","journal-title":"Biomolecules"},{"key":"2738_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.mayocp.2015.03.023","volume":"90","author":"R Ciccocioppo","year":"2015","unstructured":"Ciccocioppo R, Gallia A, Sgarella A, et al. Long-term follow-up of crohn disease fistulas after local injections of bone marrow-derived mesenchymal stem cells. Mayo Clin Proc. 2015;90:747\u201355.","journal-title":"Mayo Clin Proc"},{"key":"2738_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00384-011-1350-1","volume":"27","author":"H Guadalajara","year":"2012","unstructured":"Guadalajara H, Herreros D, De-La-Quintana P, et al. Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis. 2012;27:595\u2013600.","journal-title":"Int J Colorectal Dis"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-02738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-022-02738-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-02738-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T12:33:35Z","timestamp":1644410015000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-022-02738-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2738"],"URL":"https:\/\/doi.org\/10.1186\/s13287-022-02738-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"assertion":[{"value":"10 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the national ethics committee, and each patient gave written informed consent. The study was conducted according to the Declaration of Helsinki, as well as relevant international, national and local rules and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"L Guillo declares consulting fees for AbbVie. JC Grimaud has served as a consultant for AbbVie, Takeda and Janssen and as a speaker for AbbVie, Takeda, Janssen and MSD. M Serrero declares lecture and consulting fees for AbbVie, Celltrion, Ferring, Janssen, MSD, Takeda and Tillotts. JM received honorarium for educational support from FIDIA, HORIBA and MACOPHARMA. The remaining authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}